Table 1.
Demographic and clinical parameters for all upper tract urothelial carcinoma patients from 1992–2008 meeting inclusion criteria.
| n (%) Mean ± SD |
Total No. Observations, n=1227 |
NSM, n=320 (26.1) |
NUx, n=907 (73.9) |
p-value |
|---|---|---|---|---|
| Age, yrs | 70.2±11.0 | 71.6±10.6 | 69.7±11.1 | 0.007 |
| Gender | 0.23 | |||
| Male | 775 (63.2) | 210 (65.6) | 565 (62.3) | |
| Female | 452 (36.8) | 110 (34.4) | 342 (37.7) | |
| Marriage Status | 0.90 | |||
| Married | 468 (38.1) | 197 (61.6) | 562 (62.0) | |
| Unmarried | 759 (61.9) | 123 (38.4) | 345 (38.0) | |
| Race | 0.51 | |||
| White | 1073 (87.5) | 283 (88.4) | 790 (87.1) | |
| Afr. Am. | 44 (3.6) | 13 (4.1) | 31 (3.4) | |
| Other | 110 (8.9) | 24 (7.5) | 86 (9.5) | |
| Tumor grade | 0.001 | |||
| G1 | 247 (20.1) | 84 (26.3) | 163 (18.0) | |
| G2 | 980 (79.9) | 236 (73.7) | 744 (82.0) | |
(nephroureterectomy (NUx), nephron-sparing measures (NSM); (endoscopic therapy, segmental ureterectomy), observation), Afr. Am: African American, G1: Grade 1 (well-differentiated), G2: Grade 2 (moderately differentiated))